What are the key characteristics of chest pain that distinguish STEMI (ST-Elevation Myocardial Infarction), unstable angina, and vasoactive angina in patients presenting with chest pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Distinguishing Chest Pain Characteristics in STEMI, Unstable Angina, and Vasospastic Angina

The key distinguishing features are ECG findings and biomarkers rather than chest pain characteristics alone, as the pain quality is often indistinguishable between these conditions—all typically present with substernal chest pain described as squeezing, pressure, or tightness. 1

Shared Chest Pain Characteristics Across All Three Conditions

All three conditions present with similar chest pain quality that makes clinical distinction difficult based on symptoms alone:

  • Substernal location with pain characterized as squeezing, tightness, aching, dullness, fullness, heaviness, or pressure 1
  • Duration of minutes (not seconds or continuous for hours) 1
  • Radiation to neck, jaw, epigastrium, shoulders, or arms 1, 2
  • Pain is rarely sharp or stabbing and typically does not vary with position or respiration 1
  • Patients may demonstrate Levine's sign (clenched fist over precordium) 1

Critical caveat: Up to 40% of men and 48% of women present with atypical symptoms including dyspnea, nausea, vomiting, or midepigastric discomfort, particularly in elderly patients and women. 1, 2

STEMI: Distinguishing Features

STEMI is distinguished by ECG findings showing ST-segment elevation, not by chest pain characteristics alone. 2

ECG Characteristics (Primary Distinguishing Feature)

  • ST-segment elevation on 12-lead ECG obtained within 10 minutes of presentation 3, 2
  • Represents complete coronary artery occlusion 2

Clinical Presentation

  • Chest pain typically prolonged (>20 minutes) and not relieved by nitroglycerin 1
  • Often accompanied by diaphoresis, dyspnea, or nausea 3
  • Elevated cardiac biomarkers (troponin) with rising or falling pattern 3

Timing and Severity

  • Accounts for approximately 30% of acute coronary syndromes 2
  • Associated with highest mortality risk requiring immediate reperfusion within 120 minutes 2

Unstable Angina: Distinguishing Features

Unstable angina is distinguished from STEMI by absence of ST-elevation and from NSTEMI by absence of elevated biomarkers, despite similar chest pain characteristics. 1

Three Principal Presentations

  1. Rest angina: Angina occurring at rest, prolonged (usually >20 minutes) 1
  2. New-onset severe angina: Less than 2 months duration, at least Canadian Cardiovascular Society class III severity 1
  3. Crescendo/accelerating angina: Previously diagnosed angina that is increasing in intensity, duration, or frequency 1

ECG Characteristics

  • May show ST-segment depression (as little as 0.05 mV is prognostically significant) 1
  • May show transient T-wave inversions 1
  • May have normal or nondiagnostic ECG (does not rule out unstable angina) 3
  • No ST-segment elevation (this would indicate STEMI) 1

Biomarker Profile

  • Negative cardiac biomarkers (troponin, CK-MB) on at least 2 samples collected 6 hours apart 1
  • This is the key distinction from NSTEMI 1

Risk Stratification Features

Higher-risk unstable angina (worse prognosis) presents with: 1, 4

  • Rest pain (worse outcome than new-onset or accelerating angina without rest pain)
  • ST-segment depression on ECG
  • Angina despite antianginal treatment
  • Secondary unstable angina (presence of extracardiac conditions intensifying ischemia like anemia, hypotension, fever)

Vasospastic (Prinzmetal's) Angina: Distinguishing Features

Vasospastic angina is distinguished by its temporal pattern (occurring at rest, often at night or early morning) and transient ST-segment elevation that resolves when pain subsides. 1

Pathophysiology

  • Caused by intense focal spasm of epicardial coronary artery 1
  • Represents dynamic obstruction rather than fixed atherosclerotic narrowing 1
  • May occur on top of atherosclerotic plaque or in angiographically normal vessels 1

Temporal Pattern (Key Distinguishing Feature)

  • Occurs at rest, typically during nighttime or early morning hours 1
  • Cyclical pattern with pain occurring at similar times
  • Not provoked by exertion (unlike typical stable angina)

ECG Characteristics During Episode

  • Transient ST-segment elevation during chest pain 1
  • ST-segments normalize when pain resolves (unlike STEMI where elevation persists)
  • May show ventricular arrhythmias during spasm

Response to Treatment

  • Dramatic response to nitrates and calcium channel blockers 1
  • Does not respond to beta-blockers (may worsen due to unopposed alpha-vasoconstriction)

Biomarkers

  • Typically normal troponins unless prolonged spasm causes myocardial necrosis 1

Algorithmic Approach to Differentiation

Step 1: Immediate ECG (Within 10 Minutes)

  • ST-elevation present → STEMI (proceed to immediate reperfusion) 3, 2
  • ST-depression or T-wave inversions → Unstable angina or NSTEMI (proceed to biomarkers) 3
  • Transient ST-elevation that resolves → Consider vasospastic angina 1

Step 2: Cardiac Biomarkers (High-Sensitivity Troponin)

  • Elevated with rising/falling pattern → NSTEMI 3
  • Normal on serial measurements (6+ hours apart) → Unstable angina 1

Step 3: Temporal Pattern Assessment

  • Pain at rest, nocturnal, cyclical + transient ST-elevation → Vasospastic angina 1
  • Rest pain, new-onset severe, or crescendo pattern + no ST-elevation + negative biomarkers → Unstable angina 1

Step 4: Response to Therapy

  • Abrupt termination with calcium channel blockers/nitrates → Supports vasospastic angina 1
  • Persistent pain despite medical therapy → Higher-risk unstable angina or evolving STEMI 1, 4

Critical Pitfalls to Avoid

  • Do not rely on chest pain characteristics alone to distinguish these conditions—ECG and biomarkers are essential 1
  • Do not dismiss atypical presentations, especially in women, elderly, and diabetic patients who may present with dyspnea, nausea, or epigastric discomfort rather than classic chest pain 1, 2
  • Do not assume normal initial ECG rules out acute coronary syndrome—approximately 41% of NSTE-ACS patients have neither ST-depression nor T-wave inversions 2
  • Do not wait for biomarker results to treat suspected STEMI—ECG showing ST-elevation mandates immediate reperfusion therapy 2
  • Do not use beta-blockers as first-line for suspected vasospastic angina—they may worsen coronary spasm 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Differentiating SVT Chest Pain from Acute Coronary Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Guideline

Initial Treatment Plan for Unstable Angina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis for a patient with acute severe chest pain at rest, followed by brief and mild recurrence, with a recent history of asymptomatic strenuous activity?
What is the immediate treatment for a patient presenting with Acute Coronary Syndrome (ACS) ST-Elevation Myocardial Infarction (STEMI)?
What is the immediate management for a 26-year-old male patient with Unstable Angina (UA)?
What is the most beneficial intervention in the emergency department (ED) for a patient with non-ST-elevation myocardial infarction (NSTEMI) to decrease mortality?
What are the immediate admission orders for acute coronary syndrome (ACS)?
How to confirm eradication of schistosomiasis in a patient after praziquantel treatment?
Is terbinafine (Lamisil) cream safe for an elderly patient with mild impaired renal function (Glomerular Filtration Rate (GFR) of 77)?
What is the best approach to prevent conversion from ischemic to hemorrhagic stroke in a patient with a history of ischemic stroke, currently on anticoagulants (such as warfarin) or antiplatelets (such as aspirin or clopidogrel)?
What is the treatment approach for a working-age individual with subacromial pain syndrome, possibly caused by repetitive overhead activities?
For a 38-year-old female patient with type 2 diabetes mellitus, hyperlipidemia, hypertension, and obesity with a BMI of 38, currently prescribed metformin, Ozempic (semaglutide), atorvastatin, and losartan, would an alternative hypertension medication be more suitable than losartan?
What changes does neurocysticercosis cause in the cerebrospinal fluid (CSF)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question